Salsalate
Spécifications
552-94-3Numéro CAS
209-027-4Numéro CE
2-(2-hydroxybenzoyl)oxybenzoic acidNom IUPAC
C14H10O5Formule chimique
258.23 g/molMasse molaire
Salsalate; 552-94-3; sasapyrine; Salicylsalicylic acid; Disalcid; 2-Carboxyphenyl salicylate; Disalicylic acid; Sasapyrinum; Sasapyrin; 2-(2-hydroxybenzoyl)oxybenzoic acid; Disalicylsaeure; Salsalato; Benzoic acid, 2-hydroxy-, 2-carboxyphenyl ester; 2-((2-Hydroxybenzoyl)oxy)benzoic acid; Salicylic acid, bimolecular ester; Salsalatum; NSC-49171; O-Salicylcylsalicylsaeure; Salflex; Salicyloxysalicylic acid; Disalicyclic acid; DTXSID1023572; Mono-gesic; 2-[(2-Hydroxybenzoyl)oxy]benzoic acid; CHEBI:9014; V9MO595C9I; Salicylic acid bimolecular ester; NSC49171; DTXCID203572; 4-10-00-00165 (Beilstein Handbook Reference); 2-((2-hydroxyphenyl)carbonyloxy)benzoic acid; 2-[(2-hydroxyphenyl)carbonyloxy]benzoic acid; Salsitab; Salsalate Rx; RefChem:58291; N02BA06; 209-027-4; Diplosal; Salicyloylsalicylic acid; Saloxium; Salysal; Diacesal; Sasapirin; Disalyl; Nobacid; Salical; Salina; o-Salicylsalicylic acid; Sal Ester Sal; Salicylic acid, salicylate; Salsalatum [INN-Latin]; MFCD00020252; 2-Hydroxybenzoic acid 2-carboxyphenyl ester; Sasapyrine (JAN); Salsalate (Standard); Salicylsalicylic acid;Disalicylic acid; NCGC00096014-01; SASAPYRINE [JAN]; Salicylic Acid Salicylate; Salsalato [INN-Spanish]; O-Salicyloylsalicylic Acid; Disalcid (TN); CAS-552-94-3; 2-(2-hydroxyphenylcarbonyloxy)benzoic acid; Salsalate (USP/INN); EINECS 209-027-4; NSC 49171; 2-Salicyloyloxybenzoic Acid; BRN 2590908; UNII-V9MO595C9I; Disalgesic; 2-[(2-Hydroxybenzoyl)oxy]benzoic Acid (Salicylsalicylic Acid); Sasapyrine?; Salsalate [USAN:USP:INN:BAN]; Aspirin Impurity E; Salicylic Acid 2-Carboxyphenyl Ester; carboxyphenyl salicylate; Spectrum_001998; SALSALATE [INN]; SALSALATE [MI]; Aspirin EP Impurity E; SALSALATE [USAN]; Spectrum2_000693; Spectrum3_000173; Spectrum4_000940; Spectrum5_000670; SALSALATE [VANDF]; Epitope ID:613456; SALSALATE [MART.]; SALSALATE [USP-RS]; SALSALATE [WHO-DD]; 2-{[(2-hydroxyphenyl)carbonyl]oxy}benzoic acid; SCHEMBL15562; BSPBio_001665; KBioGR_001500; KBioSS_002572; SPECTRUM200331; Salsalate - Bio-X trade mark; SPBio_000845; CHEMBL154111; orb1224688; orb1310554; SALSALATE [USP IMPURITY]; Salsalate, >=98% (HPLC); SCHEMBL18096513; SCHEMBL29362887; BDBM85244; HY-B1245R; KBio2_002563; KBio2_005131; KBio2_007699; KBio3_001165; MSK8004; SALSALATE [USP MONOGRAPH]; GLXC-08143; HMS2091A05; HMS3652P07; HMS3885J09; HMS5082F08; HMS6018B18; Pharmakon1600-00200331; HY-B1245; NSC_5161; Benzoic acid, 2-carboxyphenyl ester; Tox21_111548; CCG-39652; EBC-26349; MSK8004-100A; NSC755823; s4188; SBB003097; AKOS003368478; Tox21_111548_1; CS-4891; DB01399; FS27786; NSC-755823; NCGC00096014-02; NCGC00096014-03; NCGC00096014-05; AC-18298; AS-12645; BS300124; CAS_552-94-3; ST083489; 2-[(2-Hydroxybenzoyl)oxy]benzoic acid #; SBI-0206687.P002; DB-020760; CS-0694787; NS00009927; SW219189-1; T0498; C75590; D00428; Sasapyrine Solution in Acetonitrile, 100ug/mL; AB01563259_01; AB01563259_02; F241207; SR-05000001536; CARBASALATE CALCIUM IMPURITY D [EP IMPURITY]; Q1320691; SR-05000001536-1; ACETYLSALICYLIC ACID IMPURITY E [EP IMPURITY]; BRD-K48892307-001-04-1; BRD-K48892307-001-05-8; Aspirin Impurity E; Acetylsalicylic Acid EP Impurity E; DL-LYSINE ACETYLSALICYLATE IMPURITY M [EP IMPURITY]; Salsalate, United States Pharmacopeia (USP) Reference Standard; Salsalate (Aspirin Impurity E), Pharmaceutical Secondary Standard; Certified Reference MaterialSynonymes
